National Health Investors, Inc. (NHI)

In the past six months, NHI's stock has been impacted by several events, including the announcement of its Fourth Quarter 2025 Earnings Release and Conference Call Dates in late January 2026. In December 2025, NHI announced $89.2 million in new investments and provided updates on its pipeline. Earlier, in November 2025, the company announced its Fourth Quarter 2025 Dividend. In August 2025, NHI raised its 2025 normalized Funds From Operations (FFO) guidance to $4.80 and increased its dividend, driven by a surge in Senior Housing Operating Portfolio (SHOP) Net Operating Income (NOI). The stock reached a new 1-year high in February 2026. Additionally, in February 2026, NHI announced a $105.5 million SHOP investment.

National Health Investors, Inc.'s Senior Housing Operating Portfolio (SHOP) typically experiences seasonality, which can result in slower Net Operating Income (NOI) growth in the first quarter. Despite this, management has expressed confidence in achieving 12%-15% NOI growth for the full year. Historically, August has shown the highest probability of positive returns for NHI stock at 75.00%, while September has the lowest probability at 38.46%.

National Health Investors, Inc. (NHI) is a REIT established in 1991, specializing in senior housing and medical properties. NHI operates in the Real Estate sector, specifically in Healthcare Facilities or Healthcare REITs. NHI's portfolio includes independent living, assisted living, memory care communities, skilled nursing facilities, medical office buildings, and specialty hospitals. NHI generates revenue through long-term lease agreements and also engages in sale-leaseback, joint-venture, mortgage, and mezzanine financing.

National Health Investors, Inc. has a substantial market presence across the United States, primarily investing in healthcare properties throughout the country. As of December 31, 2005, the company had investments in 158 healthcare facilities located in 18 states.

National Health Investors, Inc. generally holds a positive to moderate reputation among analysts. The company has a consensus rating of "Moderate Buy" from analysts, with an average rating score of 2.86 based on 1 strong buy, 4 buy, and 2 hold ratings. Analysts have expressed optimism about the current investment landscape, citing an actionable pipeline exceeding $1.9 billion, improved cost of capital, and reduced traditional competition in the senior housing sector. NHI's strategic positioning and expansion of its SHOP platform are also seen as positive drivers. In the first quarter of 2025, NHI incurred approximately $0.3 million in proxy contest and related expenses for a proxy campaign associated with the company's 2025 annual stockholders meeting. While this indicates a challenge, the overall sentiment from recent analyst reports and company performance suggests a generally stable and improving reputation.

Major institutional owners of National Health Investors, Inc. include Vanguard Group Inc. (13.64%), BlackRock, Inc., State Street Corp, Principal Financial Group Inc. (3.50%), Jpmorgan Chase & Co, Sound Income Strategies LLC (0.54%), and UBS Group AG (0.41%). Individual insiders who own company stock include Charlotte A Swafford and James R Jobe. Insider trading activity in late January and early February 2026 shows both buy and sell transactions by executives and independent directors.